Emmes completes third ACTT clinical trial for COVID
The ACTT-III trial assessed the efficacy and safety of interferon beta-1a plus Remdesivir compared to Remdesivir alone in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Emmes
MedGenome and Emmes launch strategic partnership focussed on advancing rare disease research
During its recognition of Rare Disease Day on 5th March, 2021, the US Food and Drug Administration (FDA) noted, patients with rare…